Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities

Mostrar otras versiones (1)

ATR and CHK1 maintain cancer cell survival under replication stress and inhibitors of both kinases are currently undergoing clinical trials. As ATR activity is increased after CHK1 inhibition, we hypothesized that this may indicate an increased reliance on ATR for survival. Indeed, we observe that r...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanjiv, Kumar, Hagenkort, Anna, Calderón-Montaño, José Manuel, Koolmeister, Tobias, Reaper, Philip M., Mortusewicz, Oliver, Jacques, Sylvain A., Kuiper, Raoul V., Schultz, Niklas, Scobie, Martin, Charlton, Peter A., Pollard, John R., Berglund, Ulrika Warpman, Altun, Mikael, Helleday, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cell Press 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713868/
https://www.ncbi.nlm.nih.gov/pubmed/26748709
http://dx.doi.org/10.1016/j.celrep.2015.12.032
Mostrar todas las versiones(2)

Ejemplares similares